SCHEMBL2347668

SCHEMBL2347668

CCCC(=O)OCc1cc(C#N)ccc1C(O)CCC(c1ccc(F)cc1)N(C)C

nearest known ligand 0.32

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 4/20 0.32
NSD2 O96028 1/20 0.32
MCHR1 Q99705 1/20 0.32
CXCR2 P25025 2/20 0.31
CHRNB2 P17787 1/20 0.31
CHRNB4 P30926 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30
CYP2J2 P51589 1/20 0.30
AOC3 Q16853 1/20 0.30
TBXA2R P21731 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27702058 0.82 AOC3 (0.36) EPHX2NSD2MCHR1CYP2C9CYP2C19
SCHEMBL3986098 0.82 AOC3 (0.36) EPHX2NSD2MCHR1CYP2C9CYP2C19
SCHEMBL27816963 0.82 AOC3 (0.36) EPHX2NSD2MCHR1CYP2C9CYP2C19
Bromide SCHEMBL4734510 0.81 AOC3 (0.36) EPHX2NSD2MCHR1CYP2C9CYP2C19
SCHEMBL1363412 0.69 SLC6A4 (0.36) CYP2C9CYP2C19
SCHEMBL1363413 0.69 SLC6A4 (0.36) CYP2C9CYP2C19
SCHEMBL5546003 0.69 NPC1 (0.37) EPHX2NSD2CYP2C9CYP2C19CYP2J2
SCHEMBL1361412 0.68 CXCR2 (0.34) NSD2CXCR2CYP2C9TBXA2R
SCHEMBL1361410 0.67 NSD2 (0.31) NSD2CXCR2CYP2C9TBXA2R
SCHEMBL6580186 0.66 AOC3 (0.36) AOC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2360150-A1 Method for the separation of intermediates which may be used for the preparation of escitalopram H. Lundbeck A/S (DK) 2011-08-24 EP disclosed